Suppr超能文献

儿科肥胖症药物治疗临床指南。

Clinician's Guide for Pediatric Anti-obesity Medications.

机构信息

Harvard Medical School, Massachusetts General Hospital, Weight Center at Massachusetts General Hospital, Boston, MA, USA.

Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Pediatr Clin North Am. 2024 Oct;71(5):957-980. doi: 10.1016/j.pcl.2024.07.006.

Abstract

The recent advent of highly effective anti-obesity medications (AOM) provides pediatric clinicians a powerful tool to augment the treatment of obesity and improve outcomes. The 2023 American Academy of Pediatrics guidelines state clinicians "should offer adolescents 12 years and older with obesity weight loss pharmacotherapy, according to medication indications, risks, and benefits, as an adjunct to health behavior and lifestyle treatment". This article will provide an update on the integration of AOM into practice, emphasizing clinical pearls and practical tips.

摘要

最近出现了非常有效的抗肥胖药物 (AOM),为儿科临床医生提供了一种强大的工具,可增强肥胖症的治疗效果并改善治疗结果。2023 年美国儿科学会指南指出,“根据药物的适应证、风险和益处,临床医生应为 12 岁及以上肥胖的青少年提供减肥药物治疗,作为健康行为和生活方式治疗的辅助手段”。本文将重点介绍临床要点和实用技巧,提供有关将 AOM 融入实践的最新信息。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验